Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials

BACKGROUND: The prognosis of patients with gastrointestinal stromal tumor (GIST) after the failure of standard therapies is poor with supportive care alone. Guidelines recommend clinical trials, and patients with good performance status following standard therapies are often eligible for phase I cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagatani, Yoshiaki, Shitara, Kohei, Bando, Hideaki, Kuboki, Yasutoshi, Okamoto, Wataru, Kojima, Takashi, Yoshino, Takayuki, Nishida, Toshirou, Ohtsu, Atushi, Doi, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109764/
https://www.ncbi.nlm.nih.gov/pubmed/27842521
http://dx.doi.org/10.1186/s12885-016-2939-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109764/
https://www.ncbi.nlm.nih.gov/pubmed/27842521
http://dx.doi.org/10.1186/s12885-016-2939-0

Ejemplares similares